Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii

The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new recombinant Bacillus Calmette–Guérin (rBCG) vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Komine-Aizawa, Shihoko, Mizuno, Satoru, Matsuo, Kazuhiro, Namiki, Takahiro, Hayakawa, Satoshi, Honda, Mitsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618695/
https://www.ncbi.nlm.nih.gov/pubmed/34835191
http://dx.doi.org/10.3390/vaccines9111260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618695/
https://www.ncbi.nlm.nih.gov/pubmed/34835191
http://dx.doi.org/10.3390/vaccines9111260

Ejemplares similares